Hutchison Pharmaceuticals (Hong Kong) Limited

HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. It is among the first global-focused novel drug discovery companies in China. Over the past two decades, it has established a fully integrated R&D platform with world-class discovery and development capabilities, with its first three medicines marketed in China, and one approved around the world including in the US, Europe and Japan. HUTCHMED also has a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes its novel oncology products, as well as prescription drugs and consumer health products in China.